Market Cap (In USD)
16.5 Million
Revenue (In USD)
7.14 Million
Net Income (In USD)
-2.17 Million
Avg. Volume
90 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.8-26.38
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- US15713L1098
- CUSIP
- -
- CIK
- 1053691
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. John J. Alam M.D.
- Employee Count
- -
- Website
- https://www.cervomed.com
- Ipo Date
- 2008-05-23
- Details
- CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
More Stocks
-
CRGX
-
HXLHexima Limited
HXL
-
SESNSesen Bio, Inc.
SESN
-
ATMCW
-
BUGLFBluGlass Limited
BUGLF
-
ALQWAQwamplify
ALQWA
-
300102Xiamen Changelight Co., Ltd.
300102
-
PTOSP2 Solar, Inc
PTOS